NCT05022732View on ClinicalTrials.gov

Polyglucosamine L112 in Overweight and Obese Subjects

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 5, 2020

Primary Completion Date

August 5, 2020

Study Completion Date

August 19, 2021

Conditions
Obesity
Interventions
DIETARY_SUPPLEMENT

Polyglucosamine L112

750 mg of chitosan for tablet formulated with ascorbic acid and tartaric acids in the relative proportions of 91-6-3% with the addition of formulating excipients

COMBINATION_PRODUCT

Placebo

excipients and gum arabic

Trial Locations (1)

27100

Azienda di Servizi alla Persona, Pavia

All Listed Sponsors
lead

Azienda di Servizi alla Persona di Pavia

OTHER

NCT05022732 - Polyglucosamine L112 in Overweight and Obese Subjects | Biotech Hunter | Biotech Hunter